A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors

Physica Medica

Volumn 30, Issue 6, 2014, Pages 635-643

  Bergamino, M ^a   Bonzano, L ^a   Levrero, F ^b   Mancardi, G L ^a   Roccatagliata, L ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Blood brain barrier; Magnetic resonance imaging; Permeability

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

BLOOD BRAIN BARRIER; BRAIN TUMOR; COMPARTMENT MODEL; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; KINETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; REVIEW; SIGNAL NOISE RATIO; ANIMAL; BIOLOGICAL MODEL; BRAIN NEOPLASMS; DIAGNOSTIC USE; IMAGE PROCESSING; PROCEDURES;

ANIMALS; BRAIN NEOPLASMS; CONTRAST MEDIA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL;

EID: 84906281093     PISSN: 11201797     EISSN: 1724191X     Source Type: Journal    
DOI: 10.1016/j.ejmp.2014.04.005     Document Type: Review

References (100)

1. Kandel E., Schwartz J., Jessel T.M. Principles of neural science 1991, 3 ed.
2. Fukumura D., Xu L., Chen Y., Gohongi T., Seed B., Jain R.K. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors invivo. Cancer Res 2001, 61:6020-6024.
3. Zagzag D., Hooper A., Friedlander D.R., Chan W., Holash J., Wiegand S.J., et al. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 1999, 159:391-400.
4. Schwickert H.C., Stiskal M., Roberts T.P., van Dijke C.F., Mann J., Muhler A., et al. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. Radiology 1996, 198:893-898.
5. Roberts H.C., Roberts T.P., Brasch R.C., Dillon W.P. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000, 21:891-899.
6. Larsson H.B., Stubgaard M., Frederiksen J.L., Jensen M., Henriksen O., Paulson O.B. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990, 16:117-131.
7. Tofts P.S., Kermode A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991, 17:357-367.
8. Lassen N.A., P W.P. Tracer kinetic methods in medical physiology 1979, New York.
9. Jacquez J.A. Compartmental analysis in biology and medicine 1985, Michigan.
10. Tofts P.S., Brix G., Buckley D.L., Evelhoch J.L., Henderson E., Knopp M.V., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. JMagn Reson Imaging 1999, 10:223-232.
11. Brix G., Ravesh M.S., Zwick S., Griebel J., Delorme S. On impulse response functions computed from dynamic contrast-enhanced image data by algebraic deconvolution and compartmental modeling. Phys Med 2011, 28:119-128.
12. Schabel M.C. Aunified impulse response model for DCE-MRI. Magn Reson Med 2012, 68:1632-1646.
13. Brix G., Griebel J., Kiessling F., Wenz F. Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements. Eur J Nucl Med Mol Imaging 2010, 37(Suppl.1):S30-S51.
14. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. JMagn Reson Imaging 1997, 7:91-101.
15. Walker H., Hall W., Hurst J. Clinical methods: the history, physical, and laboratory examinations 1990, Boston, MA. 3rd ed.
16. Dittmer DS. Dittmer DS. In: Handbooks B, editor. Handbooks CoB. 1 ed. Washington DC: Federation of American Societies for Experimental Biology; 1963. p. 540.
17. Fahraeus R., LIndqvist T. The viscosity of the blood in narrow capillary tubes. Am J Physiol 1931, 96:562-568.
18. Ewing J.R., Bagher-Ebadian H. Model selection in measures of vascular parameters using dynamic contrast-enhanced MRI: experimental and clinical applications. NMR Biomed 2013, 26:1028-1041.
19. Sourbron S.P., Buckley D.L. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2009, 66:735-745.
20. Larsson C., Kleppesto M., Rasmussen I., Salo R., Vardal J., Brandal P., et al. Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results. JMagn Reson Imaging 2013, 37:818-829.
21. Heisen M., Fan X., Buurman J., van Riel N.A., Karczmar G.S., ter Haar Romeny B.M. The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data. Magn Reson Med 2010, 63:811-816.
22. Alcaide-Leon P., Rovira A. Dynamic contrast-enhanced MR: importance of reaching the washout phase. AJNR Am J Neuroradiol 2013, 34:E58-E59.
23. Bagher-Ebadian H., Jain R., Nejad-Davarani S.P., Mikkelsen T., Lu M., Jiang Q., et al. Model selection for DCE-T1 studies in glioblastoma. Magn Reson Med 2011, 68:241-251.
24. Bergamino M., Saitta L., Barletta L., Bonzano L., Mancardi G.L., Castellan L., et al. Measurement of blood-brain barrier permeability with T1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithm. ISRN Neurosci 2013, 2013:6.
25. Srikanchana R., Thomasson D., Choyke P., Dwyer A. Acomparison of pharmacokinetic models of dynamic contrast enhanced MRI. 17th IEEE Symposium on Computer-Based Medical Systems 2004, 361-366.
26. Ingrisch M., Sourbron S. Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer. JPharmacokinet Pharmacodyn 2013, 40:281-300.
27. St Lawrence K.S., Lee T.Y. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: II. Experimental validation. JCereb Blood Flow Metab 1998, 18:1378-1385.
28. Kershaw L.E., Buckley D.L. Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI. Magn Reson Med 2006, 56:986-992.
29. Renkin E.M. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959, 197:1205-1210.
30. Crone C. The permeability of capillaries in various organs as determined by use of the 'Indicator diffusion' method. Acta Physiol Scand 1963, 58:292-305.
31. Kershaw L.E., Cheng H.L. Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model. Magn Reson Med 2010, 64:1772-1780.
32. Koh T.S., Zeman V., Darko J., Lee T.Y., Milosevic M.F., Haider M., et al. The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow. Phys Med Biol 2001, 46:1519-1538.
33. Sourbron S. Technical aspects of MR perfusion. Eur J Radiol 2010, 76:304-313.
34. Larsson H.B., Courivaud F., Rostrup E., Hansen A.E. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. Magn Reson Med 2009, 62:1270-1281.
35. Luypaert R., Sourbron S., Makkat S., de Mey J. Error estimation for perfusion parameters obtained using the two-compartment exchange model in dynamic contrast-enhanced MRI: a simulation study. Phys Med Biol 2010, 55:6431-6443.
36. Brix G., Semmler W., Port R., Schad L.R., Layer G., Lorenz W.J. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. JComput Assist Tomogr 1991, 15:621-628.
37. Chikui T., Obara M., Simonetti A.W., Ohga M., Koga S., Kawano S., et al. The principal of dynamic contrast enhanced MRI, the method of pharmacokinetic analysis, and its application in the head and neck region. Int J Dent 2012, 2012:480659.
38. Eliat P.A., Olivie D., Saikali S., Carsin B., Saint-Jalmes H., de Certaines J.D. Can dynamic contrast-enhanced magnetic resonance imaging combined with texture analysis differentiate malignant glioneuronal tumors from other glioblastoma?. Neurol Res Int 2012, 2012:195176.
39. Awasthi R., Rathore R.K., Soni P., Sahoo P., Awasthi A., Husain N., et al. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers. Neuroradiology 2012, 54:205-213.
40. Cabrera A.R., Cuneo K.C., Desjardins A., Sampson J.H., McSherry F., Herndon J.E., et al. Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial. Int J Radiat Oncol Biol Phys 2013, 86:873-879.
41. Singh A., Haris M., Rathore D., Purwar A., Sarma M., Bayu G., et al. Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions. JMagn Reson Imaging 2007, 26:871-880.
42. Pauliah M., Saxena V., Haris M., Husain N., Rathore R.K., Gupta R.K. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma. Magn Reson Imaging 2007, 25:1292-1299.
43. Roy B., Awasthi R., Bindal A., Sahoo P., Kumar R., Behari S., et al. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma. JComput Assist Tomogr 2013, 37:321-326.
44. Jain R. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications. NMR Biomed 2013, 26:1042-1049.
45. Lin W., Guo J., Rosen M.A., Song H.K. Respiratory motion-compensated radial dynamic contrast-enhanced (DCE)-MRI of chest and abdominal lesions. Magn Reson Med 2008, 60:1135-1146.
46. Tofts P.S. T1-weighted DCE imaging concepts: modelling, acquisition and analysis. RSNA 2010, 30-39. MAGNETOM Flash (Ed.).
47. Buonaccorsi G.A., O'Connor J.P., Caunce A., Roberts C., Cheung S., Watson Y., et al. Tracer kinetic model-driven registration for dynamic contrast-enhanced MRI time-series data. Magn Reson Med 2007, 58:1010-1019.
48. Melbourne A., Atkinson D., White M.J., Collins D., Leach M., Hawkes D. Registration of dynamic contrast-enhanced MRI using a progressive principal component registration (PPCR). Phys Med Biol 2007, 52:5147-5156.
49. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
50. Leach M.O., Morgan B., Tofts P.S., Buckley D.L., Huang W., Horsfield M.A., et al. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol 2012, 22:1451-1464.
51. Pintaske J., Martirosian P., Graf H., Erb G., Lodemann K.P., Claussen C.D., et al. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006, 41:213-221.
52. Fritz-Hansen T., Rostrup E., Larsson H.B., Sondergaard L., Ring P., Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996, 36:225-231.
53. Stanisz G.J., Henkelman R.M. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000, 44:665-667.
54. Lavini C., Verhoeff J.J., Majoie C.B., Stalpers L.J., Richel D.J., Maas M. Model-based, semiquantitative and time intensity curve shape analysis of dynamic contrast-enhanced MRI: a comparison in patients undergoing antiangiogenic treatment for recurrent glioma. JMagn Reson Imaging 2011, 34:1303-1312.
55. Garpebring A., Brynolfsson P., Yu J., Wirestam R., Johansson A., Asklund T., et al. Uncertainty estimation in dynamic contrast-enhanced MRI. Magn Reson Med 2012, 69:992-1002.
56. Henderson E., McKinnon G., Lee T.Y., Rutt B.K. Afast 3D look-locker method for volumetric T1 mapping. Magn Reson Imaging 1999, 17:1163-1171.
57. Yuan J., Chow S.K., Yeung D.K., Ahuja A.T., King A.D. Quantitative evaluation of dual-flip-angle T1 mapping on DCE-MRI kinetic parameter estimation in head and neck. Quant Imaging Med Surg 2012, 2:245-253.
58. Brookes J.A., Redpath T.W., Gilbert F.J., Murray A.D., Staff R.T. Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three-dimensional variable flip angle fast low-angle shot. JMagn Reson Imaging 1999, 9:163-171.
59. Wang H.Z., Riederer S.J., Lee J.N. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med 1987, 5:399-416.
60. Deoni S.C., Rutt B.K., Peters T.M. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003, 49:515-526.
61. Cheng H.L., Wright G.A. Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med 2006, 55:566-574.
62. Hsu Y.H., Ferl G.Z., Ng C.M. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab. Magn Reson Imaging 2012, 31:618-623.
63. Zhang N., Zhang L., Qiu B., Meng L., Wang X., Hou B.L. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. JMagn Reson Imaging 2012, 36:355-363.
64. Schabel M.C., Morrell G.R. Uncertainty in T(1) mapping using the variable flip angle method with two flip angles. Phys Med Biol 2009, 54:N1-N8.
65. Tofts P.S., Berkowitz B., Schnall M.D. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995, 33:564-568.
66. Barboriak D.P., MacFall J.R., Padua A.O., York G.E., Viglianti B.L., Dewhirst M.W. Standardized software for calculation of Ktrans and vp from dynamic T1-weighted MR images. International Society for Magnetic Resonance in Medicine Workshop on MR in Drug Development: From Discovery to Clinical Therapeutic Trials. McLean VA, USA 2004.
67. Ferl G.Z. DATforDCEMRI: an R package for deconvolution analysis and visualization of DCE-MRI Data. JStat Softw 2011, 44:1-18.
68. Morelli J.N., Runge V.M., Ai F., Attenberger U., Vu L., Schmeets S.H., et al. An image-based approach to understanding the physics of MR artifacts. Radiographics 2011, 31:849-866.
69. Jiru F., Klose U. Fast 3D radiofrequency field mapping using echo-planar imaging. Magn Reson Med 2006, 56:1375-1379.
70. Bosak E., Schiff J., Kaplan N. Radiofrequency power calibration for magnetic resonance imaging using signal phase as indicator. Magn Reson Med 1999, 41:474-478.
71. Dowell N.G., Tofts P.S. Fast, accurate, and precise mapping of the RF field invivo using the 180 degrees signal null. Magn Reson Med 2007, 58:622-630.
72. Sourbron S., Ingrisch M., Siefert A., Reiser M., Herrmann K. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med 2009, 62:205-217.
73. Haroon H.A., Patankar T.F., Zhu X.P., Li K.L., Thacker N.A., Scott M.J., et al. Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours. Br J Radiol 2007, 80:161-168.
74. Harrer J.U., Parker G.J., Haroon H.A., Buckley D.L., Embelton K., Roberts C., et al. Comparative study of methods for determining vascular permeability and blood volume in human gliomas. JMagn Reson Imaging 2004, 20:748-757.
75. Peng S.L., Chen C.F., Liu H.L., Lui C.C., Huang Y.J., Lee T.H., et al. Analysis of parametric histogram from dynamic contrast-enhanced MRI: application in evaluating brain tumor response to radiotherapy. NMR Biomed 2013, 26:443-450.
76. Mills S.J., Soh C., O'Connor J.P., Rose C.J., Buonaccorsi G., Cheung S., et al. Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: a dynamic contrast-enhanced MR imaging study. AJNR Am J Neuroradiol 2010, 31:726-731.
77. Mills S.J., Soh C., O'Connor J.P., Rose C.J., Buonaccorsi G.A., Cheung S., et al. Tumour enhancing fraction (EnF) in glioma: relationship to tumour grade. Eur Radiol 2009, 19:1489-1498.
78. Ferl G.Z., Xu L., Friesenhahn M., Bernstein L.J., Barboriak D.P., Port R.E. An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab. Magn Reson Med 2010, 63:1366-1375.
79. Roberts C., Issa B., Stone A., Jackson A., Waterton J.C., Parker G.J. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. JMagn Reson Imaging 2006, 23:554-563.
80. Glockner J.F., Hu H.H., Stanley D.W., Angelos L., King K. Parallel MR imaging: a user's guide. Radiographics 2005, 25:1279-1297.
81. Armitage P.A., Farrall A.J., Carpenter T.K., Doubal F.N., Wardlaw J.M. Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities. Magn Reson Imaging 2012, 29:305-314.
82. Barker G.J., Tofts P.S. Semiautomated quality assurance for quantitative magnetic resonance imaging. Magn Reson Imaging 1992, 10:585-595.
83. Firbank M.J., Harrison R.M., Williams E.D., Coulthard A. Quality assurance for MRI: practical experience. Br J Radiol 2000, 73:376-383.
84. Tofts P.S. QA: quality assurance, accuracy, precision and phantoms. Quantitative MRI of the brain: measuring changes caused by disease 2003, 55-81. J.W. Chichester (Ed.).
85. Ludemann L., Warmuth C., Plotkin M., Forschler A., Gutberlet M., Wust P., et al. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol 2009, 70:465-474.
86. Port R.E., Bernstein L.J., Barboriak D.P., Xu L., Roberts T.P., van Bruggen N. Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: application to glioblastoma treated with bevacizumab. Magn Reson Med 2010, 64:408-417.
87. Duhamel G., Schlaug G., Alsop D.C. Measurement of arterial input functions for dynamic susceptibility contrast magnetic resonance imaging using echoplanar images: comparison of physical simulations with invivo results. Magn Reson Med 2006, 55:514-523.
88. Taylor J.S., Tofts P.S., Port R., Evelhoch J.L., Knopp M., Reddick W.E., et al. MR imaging of tumor microcirculation: promise for the new millennium. JMagn Reson Imaging 1999, 10:903-907.
89. Parker G.J.M., Tanner S.F., L M.O. Pitfalls in the measurement of tissue permeability over short time-scales using multi-compartment models with a low temporal resolution blood input function. Proc 4th Annual Meeting ISMRM. New York, NY 1996, 1582.
90. Fusco R., Sansone M., Petrillo M., Avallone A., Delrio P., Petrillo A. Dynamic contrast enhanced magnetic resonance imaging in rectal cancer, rectal cancer - a multidisciplinary approach to management 2011, InTech. G.A. Santoro (Ed.).
91. Orton M.R., d'Arcy J.A., Walker-Samuel S., Hawkes D.J., Atkinson D., Collins D.J., et al. Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI. Phys Med Biol 2008, 53:1225-1239.
92. Hansen A.E., Pedersen H., Rostrup E., Larsson H.B. Partial volume effect (PVE) on the arterial input function (AIF) in T1-weighted perfusion imaging and limitations of the multiplicative rescaling approach. Magn Reson Med 2009, 62:1055-1059.
93. Lavini C., Verhoeff J.J. Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn Reson Imaging 2010, 28:1420-1430.
94. Ludemann L., Wust P., Gellermann J. Perfusion measurement using DCE-MRI: implications for hyperthermia. Int J Hyperthermia 2008, 24:91-96.
95. Gauthier M., Pitre-Champagnat S., Tabarout F., Leguerney I., Polrot M., Lassau N. Impact of the arterial input function on microvascularization parameter measurements using dynamic contrast-enhanced ultrasonography. World J Radiol 2012, 4:291-301.
96. Ivancevic M.K., Zimine I., Foxall D., Lecoq G., Righetti A., Didier D., et al. Inflow effect in first-pass cardiac and renal MRI. JMagn Reson Imaging 2003, 18:372-376.
97. Kassner A., Mandell D.M., Mikulis D.J. Measuring permeability in acute ischemic stroke. Neuroimaging Clin N Am 2011, 21:315-325. x-xi.
98. Gaitan M.I., Shea C.D., Evangelou I.E., Stone R.D., Fenton K.M., Bielekova B., et al. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol 2011, 70:22-29.
99. Kim Y.E., Lim J.S., Choi J., Kim D., Myoung S., Kim M.J., et al. Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression. Korean J Radiol 2013, 14:878-885.
100. Wang S., Delproposto Z., Wang H., Ding X., Ji C., Wang B., et al. Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRI. PLoS One 2013, 8:e67731.